Target intelligence / Profile preview

Fatty acid catabolism pathway

Molecular classification
Other (metabolic pathway)
01

Overview

The fatty acid catabolism pathway, also known as fatty acid oxidation, is a central metabolic process by which fatty acids are broken down to generate energy. This occurs primarily through a series of reactions called β‑oxidation, which takes place in the mitochondrial matrix. The process begins with activation of free fatty acids into acyl-CoA derivatives and their transport into mitochondria via the carnitine shuttle system. Each cycle of β‑oxidation shortens the fatty acyl chain by two carbons, producing acetyl-CoA, NADH, and FADH₂. Acetyl-CoA enters the citric acid cycle for further energy extraction while NADH and FADH₂ feed electrons into oxidative phosphorylation for ATP synthesis. Regulation is tightly controlled by hormonal signals such as insulin and glucagon.\n\nDisorders affecting this pathway can lead to severe clinical consequences due to impaired energy production and toxic accumulation of intermediates—most notably seen in inherited enzyme deficiencies that disrupt normal breakdown or transport steps.\n\nNotes on Target Validity:\nThe "Fatty acid catabolism pathway" refers broadly to a multi-step biochemical process involving many different proteins/enzymes rather than a single molecular entity such as an enzyme, receptor, transporter, etc. Therefore:\n - It is *not* considered a therapeutic target itself but comprises multiple potential targets.\n - For structured data purposes about drug targets or biomarkers at molecule level, it would be more appropriate to specify an individual component such as "Carnitine palmitoyltransferase I" or "Acyl-CoA dehydrogenase".\n\nIf you need information on any specific enzyme/protein within this pathway as a drug target (e.g., CPT1A), please specify that molecule.

Other names
Fatty acid oxidationβ-oxidationfatty acid degradationlipid catabolism
02

Biological functions

Energy productionMetabolic fuel utilizationATP generationLipid metabolism
03

Disease associations

Inherited metabolic disorders (e.g., adrenoleukodystrophy)Neurological dysfunction due to accumulation of very long-chain fatty acidsOther (energy metabolism disorders)
04

Biomarkers

Accumulation of very long-chain fatty acids in plasma/tissues for peroxisomal disordersAcylcarnitine profiles in blood for defects in carnitine shuttle or β‑oxidation enzymes

Beyond the preview

Go deeper on Fatty acid catabolism pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fatty acid catabolism pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call